The goal of the Gynecologic Cancers (GC) program is to raise the standard of care and improve clinical outcomes for all women with gynecologic malignancies, with an emphasis on addressing problems relevant to Oklahoma. Program members accomplish this goal by conducting transdisciplinary, team-based research that advances discovery of molecular mechanisms into early- and late-phase randomized trials. The Specific Aims of the GC program are:
- To discover and interrogate molecular mechanisms central to carcinogenesis;
- To investigate mechanisms underlying cancer therapy response and resistance; and
- To design and conduct early- and late-phase randomized clinical trials that advance novel discoveries and improve patient outcomes in the catchment area and nationally.